drugset / Trial / NCT00314665

Use of Thalidomide in Chronic Uveitis

NCT00314665

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This research study is for patients that have been diagnosed with chronic uveitis, a disease that causes inflammation in the eye. Patients are currently being treated with Remicade, Humira, Methotrexate and or similar chemotherapy type drugs to control this inflammation. Despite these medications, patients still have inflammation in their eyes. Patients are being asked to add an additional drug, thalidomide.

Timeline

Start
2004-01
Primary completion
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Thalidomide Other / unclassified

Indications